Cargando…

Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis

BACKGROUND: Components of carotid atherosclerotic plaques can reliably be identified and quantified using high resolution in vivo 3-Tesla CMR. It is suspected that lipid apheresis therapy in addition to lowering serum lipid levels also has an influence on development and progression of atherosclerot...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimm, Jochen M, Nikolaou, Konstantin, Schindler, Andreas, Hettich, Reinhard, Heigl, Franz, Cyran, Clemens C, Schwarz, Florian, Klingel, Reinhard, Karpinska, Anna, Yuan, Chun, Dichgans, Martin, Reiser, Maximilian F, Saam, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524023/
https://www.ncbi.nlm.nih.gov/pubmed/23194143
http://dx.doi.org/10.1186/1532-429X-14-80
_version_ 1782253257628844032
author Grimm, Jochen M
Nikolaou, Konstantin
Schindler, Andreas
Hettich, Reinhard
Heigl, Franz
Cyran, Clemens C
Schwarz, Florian
Klingel, Reinhard
Karpinska, Anna
Yuan, Chun
Dichgans, Martin
Reiser, Maximilian F
Saam, Tobias
author_facet Grimm, Jochen M
Nikolaou, Konstantin
Schindler, Andreas
Hettich, Reinhard
Heigl, Franz
Cyran, Clemens C
Schwarz, Florian
Klingel, Reinhard
Karpinska, Anna
Yuan, Chun
Dichgans, Martin
Reiser, Maximilian F
Saam, Tobias
author_sort Grimm, Jochen M
collection PubMed
description BACKGROUND: Components of carotid atherosclerotic plaques can reliably be identified and quantified using high resolution in vivo 3-Tesla CMR. It is suspected that lipid apheresis therapy in addition to lowering serum lipid levels also has an influence on development and progression of atherosclerotic plaques. The purpose of this study was to evaluate the influence of chronic lipid apheresis (LA) on the composition of atherosclerotic carotid plaques. METHODS: 32 arteries of 16 patients during chronic LA-therapy with carotid plaques and stenosis of 1–80% were matched according to degree of stenosis with 32 patients, who had recently suffered an ischemic stroke. Of these patients only the asymptomatic carotid artery was analyzed. All patients underwent black-blood 3 T CMR of the carotids using parallel imaging and dedicated surface coils. Cardiovascular risk factors were recorded. Morphology and composition of carotid plaques were evaluated. For statistical evaluation Fisher’s Exact and unpaired t-test were used. A p-value <0.05 was considered statistically significant. RESULTS: Patients in the LA-group were younger (63.5 vs. 73.9. years, p<0.05), had a higher prevalence of hypercholesterolemia and of established coronary heart disease in patients and in first-degree relatives (p<0.05, respectively). LA-patients had smaller maximum wall areas (49.7 vs. 59.6mm(2), p<0.05), showed lower prevalence of lipid cores (28.1% vs. 56.3%, p<0.05) and the lipid content was smaller than in the control group (5.0 vs. 11.6%, p<0.05). Minimum lumen areas and maximum total vessel areas did not differ significantly between both groups. CONCLUSION: Results of this study suggest that, despite a severer risk profile for cardiovascular complications in LA-patients, chronic LA is associated with significantly lower lipid content in carotid plaques compared to plaques of patients without LA with similar degrees of stenosis, which is characteristic of clinically stable plaques.
format Online
Article
Text
id pubmed-3524023
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35240232012-12-18 Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis Grimm, Jochen M Nikolaou, Konstantin Schindler, Andreas Hettich, Reinhard Heigl, Franz Cyran, Clemens C Schwarz, Florian Klingel, Reinhard Karpinska, Anna Yuan, Chun Dichgans, Martin Reiser, Maximilian F Saam, Tobias J Cardiovasc Magn Reson Research BACKGROUND: Components of carotid atherosclerotic plaques can reliably be identified and quantified using high resolution in vivo 3-Tesla CMR. It is suspected that lipid apheresis therapy in addition to lowering serum lipid levels also has an influence on development and progression of atherosclerotic plaques. The purpose of this study was to evaluate the influence of chronic lipid apheresis (LA) on the composition of atherosclerotic carotid plaques. METHODS: 32 arteries of 16 patients during chronic LA-therapy with carotid plaques and stenosis of 1–80% were matched according to degree of stenosis with 32 patients, who had recently suffered an ischemic stroke. Of these patients only the asymptomatic carotid artery was analyzed. All patients underwent black-blood 3 T CMR of the carotids using parallel imaging and dedicated surface coils. Cardiovascular risk factors were recorded. Morphology and composition of carotid plaques were evaluated. For statistical evaluation Fisher’s Exact and unpaired t-test were used. A p-value <0.05 was considered statistically significant. RESULTS: Patients in the LA-group were younger (63.5 vs. 73.9. years, p<0.05), had a higher prevalence of hypercholesterolemia and of established coronary heart disease in patients and in first-degree relatives (p<0.05, respectively). LA-patients had smaller maximum wall areas (49.7 vs. 59.6mm(2), p<0.05), showed lower prevalence of lipid cores (28.1% vs. 56.3%, p<0.05) and the lipid content was smaller than in the control group (5.0 vs. 11.6%, p<0.05). Minimum lumen areas and maximum total vessel areas did not differ significantly between both groups. CONCLUSION: Results of this study suggest that, despite a severer risk profile for cardiovascular complications in LA-patients, chronic LA is associated with significantly lower lipid content in carotid plaques compared to plaques of patients without LA with similar degrees of stenosis, which is characteristic of clinically stable plaques. BioMed Central 2012-11-29 /pmc/articles/PMC3524023/ /pubmed/23194143 http://dx.doi.org/10.1186/1532-429X-14-80 Text en Copyright ©2012 Grimm et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Grimm, Jochen M
Nikolaou, Konstantin
Schindler, Andreas
Hettich, Reinhard
Heigl, Franz
Cyran, Clemens C
Schwarz, Florian
Klingel, Reinhard
Karpinska, Anna
Yuan, Chun
Dichgans, Martin
Reiser, Maximilian F
Saam, Tobias
Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
title Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
title_full Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
title_fullStr Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
title_full_unstemmed Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
title_short Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
title_sort characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution cmr - a comparative analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524023/
https://www.ncbi.nlm.nih.gov/pubmed/23194143
http://dx.doi.org/10.1186/1532-429X-14-80
work_keys_str_mv AT grimmjochenm characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT nikolaoukonstantin characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT schindlerandreas characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT hettichreinhard characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT heiglfranz characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT cyranclemensc characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT schwarzflorian characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT klingelreinhard characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT karpinskaanna characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT yuanchun characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT dichgansmartin characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT reisermaximilianf characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis
AT saamtobias characteristicsofcarotidatheroscleroticplaquesofchroniclipidapheresispatientsasassessedbyinvivohighresolutioncmracomparativeanalysis